Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 8:28 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 625–648 of 1,551 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Ulcerative Clear all

Conditions: Diabetic Foot Ulcers
Interventions: NEOX®CORD 1K, standard of care; Other
Lead sponsor: BioTissue Holdings, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 19
States / cities: Carlsbad, California • Castro Valley, California • Fair Oaks, California + 16 more

Conditions: Catheter-Related Infections, Pressure Injury
Interventions: Patient Safety Display; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Inflammatory Bowel Disease, Crohn's Disease, Ulcerative Colitis, CD
Interventions: Bacteriotherapy; Biological
Lead sponsor: David Suskind; Other
Eligibility: 12 Years to 21 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Leg Ulcer
Interventions: Collagen ORC Antimicrobial Matrix (CAM); Device
Lead sponsor: Ethicon, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 48 participants
Timeline: 2004 – 2005
U.S. locations: 3
States / cities: Fort Lauderdale, Florida • South Miami, Florida • Warren, Pennsylvania

Conditions: Ulcerative Colitis
Interventions: Ozanimod, Placebo; Drug
Lead sponsor: Celgene; Industry
Eligibility: 18 Years to 73 Years
Enrollment: 199 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2019
U.S. locations: 10
States / cities: Anaheim, California • La Jolla, California • Oceanside, California + 7 more

Conditions: Pressure Injury, Pressure Ulcer
Interventions: LAL, Non-LAL; Device
Lead sponsor: David Brienza; Other
Eligibility: 18 Years and older
Enrollment: 457 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Pyoderma Gangrenosum
Interventions: adalimumab; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Thoracic Aortic Aneurysm, Penetrating Ulcers
Interventions: Relay Thoracic Stent-Graft; Device
Lead sponsor: Bolton Medical; Industry
Eligibility: 18 Years and older
U.S. locations: 15
States / cities: Phoenix, Arizona • Washington D.C., District of Columbia • Gainesville, Florida + 12 more

Conditions: Spinal Cord Injury, Pressure Ulcers
Interventions: Education and Counseling; Behavioral
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years and older
Enrollment: 278 participants
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 6
States / cities: Augusta, Georgia • Memphis, Tennessee • Houston, Texas + 3 more

Conditions: Chronic Venous Hypertension With Ulcer
Interventions: Standard Multi-layered Compression dressing, Standard Multi-layered Compression dressing with a cryopreserved skin allograft (TheraSkin); Procedure
Lead sponsor: Solsys Medical LLC; Industry
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Fairfax, Virginia

Conditions: HIV Infections, Stomatitis, Aphthous
Interventions: Thalidomide; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 13 Years and older
Enrollment: 164 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 1998
U.S. locations: 39
States / cities: Birmingham, Alabama • Los Angeles, California • San Francisco, California + 18 more

Conditions: Inflammatory Bowel Disease, Ulcerative Colitis, Crohn's Disease
Interventions: Curcumin; Drug
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 8 Years to 18 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Bacterial Corneal Ulcer
Interventions: ProProKera Plus®; Device
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Diabetic Foot Ulcer, Venous Leg Ulcer, Pressure Ulcer
Interventions: DETEC® Esterase; Diagnostic Test
Lead sponsor: Progenitec Inc.; Industry
Eligibility: 21 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Arlington, Texas

Conditions: Venous Leg Ulcers
Interventions: HP-802-247, Vehicle; Biological
Lead sponsor: Healthpoint; Industry
Eligibility: 18 Years and older
Enrollment: 447 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 45
States / cities: Glendale, Arizona • Phoenix, Arizona • Tucson, Arizona + 37 more

Conditions: Gastroduodenal Ulcerations, Erosion
Interventions: PL3100, Naproxen; Drug
Lead sponsor: PLx Pharma; Industry
Eligibility: 50 Years to 75 Years
Enrollment: 77 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010
U.S. locations: 2
States / cities: Dallas, Texas • Houston, Texas

Conditions: Foot Ulcer, Diabetes
Interventions: KC-002, Conventional Wound Therapy; Device · Other
Lead sponsor: KeraCure; Industry
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 21
States / cities: Montgomery, Alabama • Phoenix, Arizona • Tucson, Arizona + 18 more

Conditions: External Wounds Measured for Length by Width Using a Ruler
Interventions: "gold standard" LxW manual ruler measurement technique, WMMS ImageReview software's LxW measurement technique, WMMS ImageReview software's Visual External Wound Trace, WMMS ImageReview software's External Wound Trace Overlay; Device
Lead sponsor: Wound Vision; Industry
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 2
States / cities: Indianapolis, Indiana

Conditions: Peripheral Arterial Disease, Diabetic Foot
Interventions: PDA-002, Placebo; Biological · Other
Lead sponsor: Celularity Incorporated; Industry
Eligibility: 18 Years and older
Enrollment: 159 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 45
States / cities: Birmingham, Alabama • Mesa, Arizona • Phoenix, Arizona + 37 more

Conditions: Transtibial Amputation
Interventions: Walk, Yuga post, E-SWEAT Sensor; Procedure · Device
Lead sponsor: North Carolina State University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Raleigh, North Carolina

Conditions: Pressure Injury, Military Activity
Interventions: Mepilex, LiquiCell; Device
Lead sponsor: University of Washington; Other
Eligibility: 18 Years to 55 Years
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Diabetic Ulcers
Interventions: Vasculera; Dietary Supplement
Lead sponsor: Primus Pharmaceuticals; Industry
Eligibility: 25 Years to 85 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Diabetic Foot Ulcer
Interventions: TWO2 Device, Placebo Device; Device
Lead sponsor: AOTI Ltd.; Industry
Eligibility: 18 Years to 89 Years
Enrollment: 73 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 10
States / cities: Phoenix, Arizona • Vacaville, California • Washington D.C., District of Columbia + 6 more

Conditions: Chronic Granulomatous Disease, Inflammatory Bowel Disease
Interventions: Neocate Splash; Other
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 8 Years to 65 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Bethesda, Maryland

Search by objective public record fields.

Non-healing Diabetic Foot Ulcers (DFU) Treated With SoC With or Without NEOX®CORD 1K

Pilot Testing a Patient Safety Display in the Hospital Setting

Bacteriotherapy in Pediatric Inflammatory Bowel Disease

A Study to Evaluate the Clinical Effectiveness of a Collagen-ORC Antimicrobial Matrix in Venous Leg Ulcers

Efficacy and Safety Study of Ozanimod in Ulcerative Colitis

An RCT on Support Surfaces for Pressure Ulcer Prevention

Study to Determine the Safety and Efficacy of Adalimumab in the Treatment of Pyoderma Gangrenosum

Phase II Clinical Study of the Safety and Efficacy of the Relay Thoracic Stent-Graft

Preventing Pressure Ulcers in Veterans With Spinal Cord Injury (SCI)

Standard Compression Therapy With/Without Application of Skin Allograft (Theraskin) for Venous Leg Ulcer Treatment

Thalidomide for Treatment of Oral and Esophageal Aphthous Ulcers and HIV Viremia in Patients With HIV Infection

Curcumin in Pediatric Inflammatory Bowel Disease

Evaluating the Use of ProKera Plus® in the Management of Bacterial Corneal Ulcers

DETEC® Esterase for Screening Wound Infection at Point of Care

Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers

Clinical Trial Evaluating Gastrointestinal Damage Following Administration PL3100 or Naproxen in At-Risk Adults

Safety and Efficacy Study of an Interactive Wound Dressing (KC002) for the Treatment of Diabetic Foot Ulcers

Measuring Wounds Found on the Outside of the Body Surface

Efficacy and Safety of Intramuscular PDA-002 in Subjects With Diabetic Foot Ulcer With and Without PAD.

Epidermal Sensors for Wireless and Enhanced Amputee Skin Tracking (E-SWEAT) Part 1

Pressure Injury Prevention in AE and PFC

Safety and Efficacy of Vasculera® in the Healing of Diabetic Skin Ulcers

Efficacy, Safety and Economic Benefits of Topical Wound Oxygen Therapy in the Treatment of Chronic Diabetic Foot Ulcers

Elemental Diet for Treatment of Inflammatory Bowel Disease in Patients With Chronic Granulomatous Disease